Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia: Adaptive Platform Study

NCT07572097 is registered in ClinicalTrials.gov with Shanghai East Hospital as lead sponsor.

NCT NCT07572097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07572097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High-Frequency Irreversible Electroporation vs Standard of Care for Benign Prostatic Hyperplasia: Adaptive Platform Study
Lead sponsor
Shanghai East Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
May 5, 2026
Completion date
May 5, 2029
Enrollment
288 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bph